Back to News
Market Impact: 0.3
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a class-action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. The notice provides no allegations, damages estimate, class period, or operational details, but the litigation creates a negative legal overhang for the company and its shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
BYAH-0.90
More News
- Xencor reports phase 1 data for cancer drug XmAb819
- Biotech stocks are surging. How investors can play the new drug innovation boom
- UK immigration crackdown threatens £15 billion care sector
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- Thousands of Israelis rally against Netanyahu gov’t days before election
- Fact vs. fiction: Doctors share whether peptides are safe and effective